Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Plasma Cell Dyscrasias”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 17 of 0 results

Not applicableLooking for participantsNCT06870760
What this trial is testing

Pre-malignant States to Hematologic Malignancies in Firefighters

Who this might be right for
Clonal Hematopoiesis of Indeterminate PotentialMonoclonal GammopathyNon Hodgkin Lymphoma+3 more
Wake Forest University Health Sciences 300
Testing effectiveness (Phase 2)Study completedNCT01447914
What this trial is testing

Tivantinib in Treating Patients With Relapsed, or Relapsed and Refractory Multiple Myeloma

Who this might be right for
Refractory Multiple Myeloma
National Cancer Institute (NCI) 16
Testing effectiveness (Phase 2)Study completedNCT00821249
What this trial is testing

ARRY-520 in Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple MyelomaPlasma Cell Leukemia
Pfizer 55
Large-scale testing (Phase 3)Active Not RecruitingNCT04512235
What this trial is testing

Evaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIa AL Amyloidosis (CARES)

Who this might be right for
AL Amyloidosis
Alexion Pharmaceuticals, Inc. 281
Large-scale testing (Phase 3)Active Not RecruitingNCT04504825
What this trial is testing

Evaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIb AL Amyloidosis (CARES)

Who this might be right for
AL Amyloidosis
Alexion Pharmaceuticals, Inc. 125
Early research (Phase 1)Study completedNCT00952237
What this trial is testing

Immune Mobilization of Autologous Peripheral Blood Stem Cells Using Interleukin-2 and GM-CSF

Who this might be right for
Non-Hodgkin's LymphomaHodgkin's DiseaseMultiple Myeloma+2 more
Dartmouth-Hitchcock Medical Center 13
Not applicableEnrolling By InvitationNCT04210791
What this trial is testing

Autologous Stem Cell Transplantation for Patients With AL Amyloidosis

Who this might be right for
AL AmyloidosisPlasma Cell Dyscrasia
Nanjing University School of Medicine 500
Early research (Phase 1)Study completedNCT01248923
What this trial is testing

ARRY-520 and Bortezomib Plus Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma, Plasma Cell Leukemia
Array Biopharma, now a wholly owned subsidiary of Pfizer 55
Not applicableStudy completedNCT05032339
What this trial is testing

Evaluation of the Plasma Cell Disorders Panel on the BD FACSLyric™ Flow Cytometer

Who this might be right for
Plasma Cell Disorder
Becton, Dickinson and Company 208
Not applicableWithdrawnNCT05362331
What this trial is testing

Companion for CAR-T Web App During Chimeric Antigen Receptor T-cell Therapy

Who this might be right for
LymphomaLeukemiaPlasma Cell Dyscrasia
University of California, San Francisco
Not applicableLooking for participantsNCT01351545
What this trial is testing

Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Who this might be right for
Hematologic MalignanciesInherited Disorders of MetabolismInherited Abnormalities of Platelets+14 more
Center for International Blood and Marrow Transplant Research 99,999
Not applicableLooking for participantsNCT06760052
What this trial is testing

Longitudinal Data Registry of Plasma Cell Dyscrasia

Who this might be right for
Multiple Myeloma and Other Plasma Cell Neoplasms
Shanghai Zhongshan Hospital 2,000
Not applicableNot Yet RecruitingNCT06330896
What this trial is testing

Disease Characteristics and Treatment Response in Plasma Cell Disorders Patients Based on Genetic Abnormalities From Fluorescence In Situ Hybridization and Next Generation Sequencing

Who this might be right for
Plasma Cell Disorder
Siriraj Hospital 498
Early research (Phase 1)Looking for participantsNCT06313502
What this trial is testing

High Dose Ascorbic Acid (HDAA) in Patients With Plasma Cell Disorders

Who this might be right for
Plasma Cell Disorder
University of Arkansas 18
Not applicableStudy completedNCT02274519
What this trial is testing

Novel Support Options in Autologous Stem Cell Transplant for Multiple Myeloma

Who this might be right for
Multiple MyelomaPlasma Cell Disorder
Mayo Clinic 29
Not applicableActive Not RecruitingNCT02671448
What this trial is testing

Pilot Trial of Homebound Stem Cell Transplantation

Who this might be right for
Plasma Cell Dyscrasia
Memorial Sloan Kettering Cancer Center 83
Testing effectiveness (Phase 2)Ended earlyNCT00579111
What this trial is testing

Reduced Intensity Preparative Regimen Followed by Stem Cell Transplant (FAB)

Who this might be right for
Myelodysplastic and Myeloproliferative DisordersAcute Myelogenous LeukemiaAcute Lymphoblastic Leukemia+5 more
Baylor College of Medicine 4